tiprankstipranks
Advertisement
Advertisement

JP:4502 Stock Latest News

Takeda faces major AMITIZA antitrust verdict and prepares FY2025 provision
Company AnnouncementsTakeda faces major AMITIZA antitrust verdict and prepares FY2025 provision
3d ago
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
PremiumThe Fly
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
3d ago
TAK
Takeda told to pay hundreds of millions for generic drug delay, Bloomberg says
PremiumThe Fly
Takeda told to pay hundreds of millions for generic drug delay, Bloomberg says
3d ago
TAK
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
PremiumThe Fly
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
3d ago
TAK
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
PremiumThe Fly
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
7d ago
BA
SPY
Justice Department announces $13.67M civil settlement with Takeda
PremiumThe FlyJustice Department announces $13.67M civil settlement with Takeda
7d ago
TAK
Takeda Extends Long-Term Stock Incentive Plans for Directors and Management into 2026
Premium
Company Announcements
Takeda Extends Long-Term Stock Incentive Plans for Directors and Management into 2026
9d ago
Takeda Lifts Profit and Dividend Despite Revenue Dip, Signals Softer Earnings Ahead
Premium
Company Announcements
Takeda Lifts Profit and Dividend Despite Revenue Dip, Signals Softer Earnings Ahead
9d ago
TKPHF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TKPHF Earnings this Week: How Will it Perform?
11d ago
Takeda announces TAK-881-3001 trial in PID met primary endpoint
PremiumThe Fly
Takeda announces TAK-881-3001 trial in PID met primary endpoint
18d ago
TAK
Protagonist exercises right to opt out of 50:50 U.S. arrangement for rusfertide
PremiumThe Fly
Protagonist exercises right to opt out of 50:50 U.S. arrangement for rusfertide
24d ago
TAK
PTGX
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
PremiumThe Fly
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
1M ago
TAK
SYRE
Takeda upgraded to Outperform from Market Perform at Bernstein
PremiumThe FlyTakeda upgraded to Outperform from Market Perform at Bernstein
1M ago
TAK
Denali Therapeutics regains full rights to DNL593
Premium
The Fly
Denali Therapeutics regains full rights to DNL593
2M ago
TAK
DNLI
Abivax appoints Michael Nesrallah as chief commercial officer
Premium
The Fly
Abivax appoints Michael Nesrallah as chief commercial officer
2M ago
TAK
ABVX
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
PremiumThe Fly
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
2M ago
TAK
AXSM
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
PremiumThe Fly
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
2M ago
JNJ
TAK
Alumis price target raised to $55 from $50 at Oppenheimer
PremiumThe Fly
Alumis price target raised to $55 from $50 at Oppenheimer
2M ago
JNJ
TAK
Takeda’s Oral Psoriasis Drug Zasocitinib Shows Strong Phase 3 Results
PremiumCompany Announcements
Takeda’s Oral Psoriasis Drug Zasocitinib Shows Strong Phase 3 Results
2M ago
Takeda announces new data from Phase 3 studies of TAK-279
PremiumThe FlyTakeda announces new data from Phase 3 studies of TAK-279
2M ago
TAK
Takeda Sets June CEO Handover to Julie Kim and Overhauls Board Line-up
Premium
Company Announcements
Takeda Sets June CEO Handover to Julie Kim and Overhauls Board Line-up
2M ago
Takeda Unveils Cost-Saving Transformation to Fund Next Wave of Drug Launches
Premium
Company Announcements
Takeda Unveils Cost-Saving Transformation to Fund Next Wave of Drug Launches
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >